comparemela.com

Latest Breaking News On - Exudative age related macular degeneration - Page 3 : comparemela.com

Retina Group Warns on Complications From New GA Drug

The American Society of Retina Specialists has reported six cases of vasculitis not seen in clinical trials.

United statesDemetriosg vavvasRetina service at harvard medical schoolDrug administrationOcular regenerative medical institute at massachusetts eyeAmerican society of retina specialistsApellis pharmaceuticalsAmerican societyRetina specialistsMedscape medical newsRetina serviceHarvard medical schoolOcular regenerative medical instituteMassachusetts eyeEar infirmaryMass general hospital

FDA Declines to Approve Regeneron s Higher-Dose Eylea

US health regulators on Tuesday declined to approve a higher-dose version of Regeneron s drug Eylea for treatment of a disease that is leading cause of blindness among the elderly.

Krishna chandra eluriMaju samuel sriraj kalluvilaRoche vabysmoDavid gregorioRobyn karnauskasKhushi mandowaraRaghav mahobeDrug administrationRegeneron pharmaceuticalMaju samuelSriraj kalluvilaExudative age related macular degenerationXudative armd exudative amdWet amdNeovascular age related macular degenerationEovascular armd

Biosimilar Comparable to Aflibercept in Neovascular AMD

Investigators examined a proposed anti-VEGF biosimilar in a phase 3 trial.

United statesSamsung bioepisExudative age related macular degenerationXudative armdBiologic therapyBiosimilar drugsFollow on biologicsVegf vascular endothelial growth factorVascular endothelial growth factorAscular endothelial growth factor vegfRetinal diseaseVision care and maintenanceMacular degenerationGe related macular degeneration armdVisual acuit

Minocycline Doesn t Slow Geographic Atrophy in AMD

A potential drug for age-related macular degeneration failed to slow geographic atrophy, according to data from a long-term study.

United statesDemetrios vavvasNational eye institute intramural research programSyfovre apellis pharmaceuticalsDrug administrationNational eye instituteAssociation for researchRetina service at mass eyeHarvard medical schoolRetina serviceMass eyeApellis pharmaceuticalsNational eye institute intramural researchExudative age related macular degenerationXudative armdRetinal disease

Uncontrolled Wet AMD: Drug Switch Can Mute Disease Activity

Phase 3 data from the 2023 ARVO meeting showed treatment with the monoclonal antibody improved visual acuity in some patients.

France generalNew south walesRamin tadayoniMark gilliesBrolucizumab beovuIveric bioSrinivasr saddaDoheny eye instituteUniversity of parisAssociation for researchMacula research groupUniversity of sydney save sight instituteSaint louis university hospitalsCalifornia los angeles david geffen schoolDrug administrationSydney save sight

vimarsana © 2020. All Rights Reserved.